Sepotlet Plus - instructions for use, dose, side effects, contraindications

Similar drugsTo uncover

Dosage form: & nbsplozenges

Composition:

1 lozenge contains:

Active substances: cetylpyridinium chloride (as monohydrate) 1,00 mg

benzocaine 5,00 mg

Excipients: levomenthol 3.00 mg, peppermint mint oil 1.00 mg, maltitol liquid (dry matter) 478.00 mg, mannitol 167.50 mg, glycerol 3.50 mg, castor oil 1.10 mg, silicon dioxide colloidal, anhydrous 1.00 mg, magnesium stearate 3.00 mg, dye blue patented V (E131) 0.012 mg, titanium dioxide (E171) 3.50 mg, wax emulsion (Capol 600 Pharma) 2.50 mg, povidone 2.50 mg, maltitol up to 1140.00 mg.

Description:

Round biconvex lozenges with a smooth surface, covered with a blue coating.

Pharmacotherapeutic group:Antiseptic + local anesthetic

Pharmacodynamics:

The drug Septotelet® Plus has a local anesthetic and antimicrobial effect. The preparation contains an antiseptic cetylpyridinium chloride, which has an antimicrobial, antifungal and virucidal effect. Benzocaine is a local anesthetic that reduces pain when swallowing, which often accompanies infectious inflammatory processes in the mouth and throat.

The drug Sepotlet® plus contains polyols (maltitol and mannitol), does not contain sugar, which allows you to take the drug for people with diabetes. The sugarless medium increases the activity of the antiseptic.

Indications:

Infectious and inflammatory diseases of the mouth and throat:

- pharyngitis, laryngitis, the initial stage of angina;

- inflammation of the gums and mucous membrane of the mouth (gingivitis, stomatitis).

Contraindications:

- Hypersensitivity to any of the components of the drug;

- patients with rare hereditary intolerance to fructose;

- children's age till 6 years.

Carefully:

Diabetes; presence of open wounds of the oral cavity; cetylpyridinium chloride slows healing of wounds.

Pregnancy and lactation:

Data on the use of the drug during pregnancy and lactation are limited, so pregnant and lactating women should not take the drug.

Dosing and Administration:

Adults and children over 12 years are recommended to dissolve 1 lozenge every 2-3 hours, but not more than 8 lozenges per day.

Children from 6 to 12 years are recommended to dissolve one lozenge every 4 hours, but not more than 4 lozenges per day.

Sepoplet plus should not be taken immediately before meals and simultaneously with milk.

Side effects:

In very rare cases, allergic reactions.

From the digestive system in very rare cases, possible: nausea, diarrhea, the manifestation of which the drug should be stopped. The preparation contains polyols (maltitol, mannitol), which can cause diarrhea in large doses, especially in children.

Overdose:

Given the number of active substances contained in a single lozenge, the possibility of an overdose is minimal. Taking doses that are higher than recommended can cause disturbances in the gastrointestinal tract: nausea, vomiting and diarrhea. Benzocaine in high doses can cause methemoglobinemia, and cetylperidinium chloride - vomiting and nausea. In this case, stop taking the medication and consult a doctor.

Interaction:

The cases of interaction of Septotelet® plus with other medications have not been described. Simultaneous reception of Septotelet® Plus with food and milk can reduce local antiseptic and anesthetic effects of the drug.

Special instructions:

Do not exceed recommended doses.

Patients with diabetes mellitus should know that each lozenge contains approximately 1 g of maltintol. For its metabolism, insulin is needed, but, due to slow hydrolysis and poor absorption in the gastrointestinal tract, maltitol slightly affects the concentration of glucose in the plasma. Therefore, correction of the dose of hypoglycemic drugs is not required. The energy value of maltitol (10 kJ /r or 2.4 kcal / g) is significantly lower than that of sucrose.

With more severe infectious processes accompanied by fever, headache and vomiting, it is necessary to consult a doctor, especially if the condition does not improve within 3 days of the start of therapy.

Septollet® plus contains maltitol, so patients with rare hereditary problems of fructose intolerance should not take the drug.

Effect on the ability to drive transp. cf. and fur:

There is no evidence that the drug Sepotlet® Plus has had an impact on the ability to drive and work with complex mechanical means.

Form release / dosage:

Pastilles.

Packaging:

For 9 pastilles in a blister of the combined material PVC / PVDH-foil aluminum.2 blisters are placed in a pack of cardboard along with instructions for use.

Storage conditions:

In a dry, the dark place at a temperature of no higher than 25 ° C.

Keep out of the reach of children.

Shelf life:

3 years.

Do not use the drug after the expiration date.

Terms of leave from pharmacies:Without recipe

Registration number:P N 015445/01

Date of registration:16.11.2009

Date of cancellation:2017-04-28

The owner of the registration certificate:KRKA, dd, Novo mesto, AOKRKA, dd, Novo mesto, AO

Manufacturer: & nbsp

KRKA, d.d. Slovenia

Representation: & nbspKRKA KRKA Slovenia

Information update date: & nbsp28.04.2017

Illustrated instructions

Instructions

Septotlet® plus (Septolete® plus)